While long-term DEN-challenged WT mice (i.e. long-term cohort = 10 months treatment) developed multiple hepatic tumors, Lrh-1-deleted livers presented a significantly smaller tumors and moderate protection against hepatocellular carcinoma development (Fig. 1a, right). Here, NR5A2 is linked to hepatocellular carcinoma.